Copyright
©The Author(s) 2019.
World J Gastrointest Endosc. Mar 16, 2019; 11(3): 231-238
Published online Mar 16, 2019. doi: 10.4253/wjge.v11.i3.231
Published online Mar 16, 2019. doi: 10.4253/wjge.v11.i3.231
Table 1 Comparison of patient characteristics between the positive group and the negative group
P group (n = 76) | N group (n = 19) | P value | |
Age (yr) | 75 (29-90) | 68 (43-82) | 0.012 |
Males | 60 (78.9) | 12 (63.2) | 0.229 |
Received antithrombotic drugs | 14 (18.4) | 0 (0) | 0.064 |
Location of tumor (distal/hilar) | 45/31 | 8/11 | 0.205 |
UICC stage (1/2/3/4) | 27/29/10/10 | 7/7/3/2 | 0.91 |
Cholangitis within the last month | 10 (13.2) | 3 (15.8) | 0.719 |
- Citation: Takagi T, Sugimoto M, Suzuki R, Konno N, Asama H, Sato Y, Irie H, Watanabe K, Nakamura J, Kikuchi H, Takasumi M, Hashimoto M, Hikichi T, Ohira H. Appropriate number of biliary biopsies and endoscopic retrograde cholangiopancreatography sessions for diagnosing biliary tract cancer. World J Gastrointest Endosc 2019; 11(3): 231-238
- URL: https://www.wjgnet.com/1948-5190/full/v11/i3/231.htm
- DOI: https://dx.doi.org/10.4253/wjge.v11.i3.231